| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8771186 | The Journal of Urology | 2018 | 8 Pages |
Abstract
There is little basis for excluding patients with otherwise low risk prostate cancer on biopsy from active surveillance based on criteria such as the number of positive cores or the maximum cancer involvement of biopsy cores.
Keywords
LNIBCRPSAPRIASEPESVIPCAProstate specific antigenMRIClinical decision-makingMagnetic resonance imagingSeminal vesicle invasionLymph node involvementNeoplasm gradingRadical prostatectomyProstate cancerBiochemical recurrenceextraprostatic extensionWatchful waitingProstatic neoplasmsActive surveillanceProstatectomyGrade group
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
François Audenet, Emily A. Vertosick, Samson W. Fine, Daniel D. Sjoberg, Andrew J. Vickers, Victor E. Reuter, James A. Eastham, Peter T. Scardino, Karim A. Touijer,